Literature DB >> 3741917

Endocrine and behavioral responses to methylphenidate in normal subjects.

P R Joyce, R A Donald, M G Nicholls, J H Livesey, R M Abbott.   

Abstract

Methylphenidate (0.3 mg/kg) was administered intravenously to 20 normal subjects. Behavioral responses varied considerably among individuals. Both cortisol and growth hormone showed significant increases (p less than 0.001). The adrenocorticotrophic hormone (ACTH) response seemed insufficient to explain the increase in cortisol. For men only, the increase in cortisol correlated positively with the increase in epinephrine (r = 0.77, p less than 0.05) and correlated negatively with baseline cortisol (r = -0.70, p less than 0.05), with increase in growth hormone (r = -0.70, p less than 0.05), and with the increase in "energy" (r = -0.83, p less than 0.01). The growth hormone response varied between the sexes, and for men, the growth hormone correlated with both an increase in "energy" (r = 0.70, p less than 0.05) and "friendliness" (r = 0.68, p less than 0.05). For all subjects, baseline heart rate correlated with the increase in "energy" (r = -0.69, p less than 0.002). In a separate study, six male subjects received, on different occasions, saline and a lower dose of methylphenidate. Together, these studies show that the increases in cortisol, growth hormone, and epinephrine, and the decrease in prolactin are dose-dependent.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741917     DOI: 10.1016/0006-3223(86)90282-9

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  6 in total

Review 1.  Drugs and HPA axis.

Authors:  Alberto Giacinto Ambrogio; Francesca Pecori Giraldi; Francesco Cavagnini
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

2.  Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects.

Authors:  N D Volkow; G J Wang; S J Gatley; J S Fowler; Y S Ding; J Logan; R Hitzemann; B Angrist; J Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

3.  Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial.

Authors:  Joshua A Samuels; Kathy Franco; Fiona Wan; Jonathan M Sorof
Journal:  Pediatr Nephrol       Date:  2005-10-28       Impact factor: 3.714

4.  Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects.

Authors:  Patrick C Dolder; Felix Müller; Yasmin Schmid; Stefan J Borgwardt; Matthias E Liechti
Journal:  Psychopharmacology (Berl)       Date:  2017-05-27       Impact factor: 4.530

5.  Personalized Connectome Mapping to Guide Targeted Therapy and Promote Recovery of Consciousness in the Intensive Care Unit.

Authors:  Brian L Edlow; Megan E Barra; David W Zhou; Andrea S Foulkes; Samuel B Snider; Zachary D Threlkeld; Sourish Chakravarty; John E Kirsch; Suk-Tak Chan; Steven L Meisler; Thomas P Bleck; Joseph J Fins; Joseph T Giacino; Leigh R Hochberg; Ken Solt; Emery N Brown; Yelena G Bodien
Journal:  Neurocrit Care       Date:  2020-08-13       Impact factor: 3.210

6.  Stress-Induced In Vivo Recruitment of Human Cytotoxic Natural Killer Cells Favors Subsets with Distinct Receptor Profiles and Associates with Increased Epinephrine Levels.

Authors:  Marc B Bigler; Simon B Egli; Cédric M Hysek; Gideon Hoenger; Laurent Schmied; Fabian S Baldin; Florian A Marquardsen; Mike Recher; Matthias E Liechti; Christoph Hess; Christoph T Berger
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.